medRxivGenetic & Genomic MedicinePreprint
Assessment of adaptive functioning in Angelman syndrome using the Vineland Adaptive Behavior Scales, Third Edition
Sarah Nelson PotteriD, Julia ZhangiD, Batsheva FriedmaniD, Julia M. GableiD, Nadia AliiD, Rene L. Barbieri‐Welge, Ayala Ben-TalliD, Kelly E. CaravellaiD, Margaret DeRamusiD, Dea GariciD, M. MacKay, Kara MuriasiD, Sarika U. PetersiD, Kimberly Smyth, Jane SummersiD, Angel Wang, Mark D. SheniD, Joerg F. HippiD, Julian TillmanniD, Jorrit TjeertesiD, Brenda Vincenzi, Lynne M. BirdiD, Wen‐Hann TaniD, Anne WheeleriD, Anjali SadhwaniiD
Abstract
PurposeThis study examined longitudinal trajectories of adaptive functioning in 331 individuals with Angelman syndrome (AS) using the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) and examined differences by molecular subtype. MethodsA total of 331 individuals (156 females, 47%) with genetically confirmed AS (ages 6 months to 52 years) were assessed between 2018 and 2025, including 207 with a deletion subtype, 63 with uniparental disomy or imprinting defect, and 61 with a UBE3A point mutation. Growth scale values were analyzed using linear mixed-effects models with log2-transformed age. ResultsIndividuals with deletion subtypes demonstrated significantly lower adaptive functioning across domains compared to those with non-deletion subtypes. Adaptive skills across all Vineland-3 subdomains increased nonlinearly with age, showing faster growth early in life that slowed over time, with largely parallel trajectories across subtypes. ConclusionIndividuals with AS demonstrate slow but steady growth in adaptive functioning that continues into adulthood, with progress varying by molecular subtype. These findings provide updated natural history benchmarks and demonstrate the utility of the Vineland-3 for clinical trials.
- organism: human
- assay: electronic health records
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi Panel
Sonya Powers, Katherine N. Anderson, … Katalin Buzási·Value in HealthPeer-reviewed·Jan 5, 2026
- Utility of at-home video recordings for functional skill assessment in Angelman Syndrome: a pilot study
Mindy Leffler, Rebecca Woods, … Anjali Sadhwani·medRxiv·Oct 6, 2025
- Gait as a Quantitative Translational Outcome Measure inAngelman Syndrome
Stela P. Petkova, Anna Adhikari, … Jill L. Silverman·Autism ResearchPeer-reviewed·Mar 10, 2022
- Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome
E. Berg, S. Petkova, … J. L. Silverman·bioRxiv·Aug 13, 2021
- Aberrant accumulation of α-synuclein might be linked with the progressive motor deficits in a mouse model of Angelman syndrome
Sagarika Das, Bhaskarjyoti Giri, Nihar Ranjan Jana·bioRxiv·Sep 3, 2026
- A preclinical pig model of Angelman syndrome mirrors the early developmental trajectory of the human condition
Luke S. Myers, Sarah Christian, … Scott V. Dindot·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 21, 2025